Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,264,458,582
-$64,278,311 QoQ
Shares Held
3,491,822
-7.5% QoQ
Ownership
0.646%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#24
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. AMGN ranks #9 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,264,458,582 | 3,491,822 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,328,736,893 | 3,776,430 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,175,769,526 | 3,592,220 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $960,631,656 | 3,404,081 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,024,222,690 | 3,668,288 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,208,401,194 | 3,878,675 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $960,774,293 | 3,686,212 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,368,523,819 | 4,247,304 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,270,297,028 | 4,065,601 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,141,696,340 | 4,015,533 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,374,736,452 | 4,773,059 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $977,896,964 | 3,638,551 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $875,454,831 | 3,943,135 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,284,066,485 | 5,311,547 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,792,282,147 | 6,824,102 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,961,229,966 | 8,701,109 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,168,139,724 | 8,911,384 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,725,908,270 | 7,137,161 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,818,695,722 | 8,084,170 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,075,226,892 | 9,758,885 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $2,654,500,630 | 10,890,259 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,796,817,724 | 11,240,777 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,168,751,919 | 13,781,976 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $3,609,632,675 | 14,202,206 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,031,860,417 | 17,094,295 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $3,577,505,960 | 17,646,653 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||